BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23797219)

  • 41. Assessment of hypoxic subvolumes in laryngeal cancer with (18)F-fluoroazomycinarabinoside ((18)F-FAZA)-PET/CT scanning and immunohistochemistry.
    Bruine de Bruin L; Bollineni VR; Wachters JE; Schuuring E; van Hemel BM; van der Wal JE; Slagter-Menkema L; de Bock GH; Steenbakkers RJ; Langendijk JA; Pruim J; van der Laan BF; Halmos GB
    Radiother Oncol; 2015 Oct; 117(1):106-12. PubMed ID: 26250803
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CT quantitative analysis study for angiogenesis, and degree of ischemic necrosis and glucose metabolite in non-small cell lung cancer.
    Jiang M; Lu HY; Shan XH; Xu W; Geng XD; Lu C; Chen JH
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4146-4155. PubMed ID: 30024603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET/CT utilizing multimodality fusion techniques.
    Garcia-Parra R; Wood D; Shah RB; Siddiqui J; Hussain H; Park H; Desmond T; Meyer C; Piert M
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1816-23. PubMed ID: 21833840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?
    Obara P; Liu H; Wroblewski K; Zhang CP; Hou P; Jiang Y; Chen P; Pu Y
    Nucl Med Commun; 2015 Aug; 36(8):782-9. PubMed ID: 25888358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation between vascular endothelial growth factor and quantitative dual-energy spectral CT in non-small-cell lung cancer.
    Li GJ; Gao J; Wang GL; Zhang CQ; Shi H; Deng K
    Clin Radiol; 2016 Apr; 71(4):363-8. PubMed ID: 26873627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1α, prognosis and
    Shen LF; Zhou SH; Yu Q
    Transl Cancer Res; 2020 Apr; 9(4):2824-2837. PubMed ID: 35117639
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between imaging and tissue biomarkers of hypoxia in squamous cell cancer of the head and neck.
    Kunder S; Chatterjee A; Manna S; Mahimkar M; Patil A; Rangarajan V; Budrukkar A; Ghosh-Laskar S; Agarwal JP; Gupta T
    World J Nucl Med; 2021; 20(3):228-236. PubMed ID: 34703390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypoxia Imaging and Biological Evaluation of the Radiosensitizing Effect of Oleanolic Acid.
    Wang H; Zhang Y; Yu W; Xue Y; Xiao L; Xu H
    Biomed Res Int; 2018; 2018():2694679. PubMed ID: 30246018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia.
    Mandeville HC; Ng QS; Daley FM; Barber PR; Pierce G; Finch J; Burke M; Bell A; Townsend ER; Kozarski R; Vojnovic B; Hoskin PJ; Goh V
    Radiology; 2012 Aug; 264(2):581-9. PubMed ID: 22700554
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism.
    Hunter GJ; Hamberg LM; Choi N; Jain RK; McCloud T; Fischman AJ
    Clin Cancer Res; 1998 Apr; 4(4):949-55. PubMed ID: 9563889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Prospective Investigation of Tumor Hypoxia Imaging with
    Mokoala KMG; Lawal IO; Maserumule LC; Hlongwa KN; Ndlovu H; Reed J; Bida M; Maes A; van de Wiele C; Mahapane J; Davis C; Jeong JM; Popoola G; Vorster M; Sathekge MM
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parametric methods for quantification of 18F-FAZA kinetics in non-small cell lung cancer patients.
    Verwer EE; Bahce I; van Velden FH; Yaqub M; Schuit RC; Windhorst AD; Raijmakers P; Hoekstra OS; Lammertsma AA; Smit EF; Boellaard R
    J Nucl Med; 2014 Nov; 55(11):1772-7. PubMed ID: 25324522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor hypoxia imaging with [F-18] fluoronitroimidazole in non-small-cell lung cancer.
    Yasuda H; Kaneta T; Takai Y; Nakayama K; Iwata R; Ito M; Tsujitani M; Takahashi S; Yamada S; Sasaki T; Yanagihara K; Yamaya M
    J Am Geriatr Soc; 2007 Jul; 55(7):1142-4. PubMed ID: 17608896
    [No Abstract]   [Full Text] [Related]  

  • 54. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
    Yang DJ; Wallace S; Cherif A; Li C; Gretzer MB; Kim EE; Podoloff DA
    Radiology; 1995 Mar; 194(3):795-800. PubMed ID: 7862981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiogenesis in non-small cell lung cancer: microvessel area in needle biopsy in vascular tumor density.
    Irion LC; Prolla JC; Hartmann AA; Irion KL; Da Silva VD
    Anal Quant Cytol Histol; 2008 Apr; 30(2):83-91. PubMed ID: 18561744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia.
    Beppu T; Sasaki T; Terasaki K; Saura H; Mtsuura H; Ogasawara K; Sasaki M; Ehara S; Iwata R; Takai Y
    Ann Nucl Med; 2015 May; 29(4):336-41. PubMed ID: 25618012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation of blood flow assessed by CT perfusion imaging and microvascular ultrastructure in non-small cell lung cancer: a preliminary study].
    Zhou H; Liu JK; Chen SX; Xiong Z; Lin GQ; Zhou ML; Chen W; Lü H
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):193-7. PubMed ID: 23879999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
    Grönroos T; Eskola O; Lehtiö K; Minn H; Marjamäki P; Bergman J; Haaparanta M; Forsback S; Solin O
    J Nucl Med; 2001 Sep; 42(9):1397-404. PubMed ID: 11535732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
    Mapelli P; Callea M; Fallanca F; Castellano A; Bailo M; Scifo P; Bettinardi V; Conte GM; Monterisi C; Rancoita PMV; Incerti E; Vuozzo M; Gianolli L; Terreni M; Anzalone N; Picchio M
    Nucl Med Commun; 2021 Jul; 42(7):763-771. PubMed ID: 33741855
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.